JP2022534586A5 - - Google Patents
Info
- Publication number
- JP2022534586A5 JP2022534586A5 JP2021570514A JP2021570514A JP2022534586A5 JP 2022534586 A5 JP2022534586 A5 JP 2022534586A5 JP 2021570514 A JP2021570514 A JP 2021570514A JP 2021570514 A JP2021570514 A JP 2021570514A JP 2022534586 A5 JP2022534586 A5 JP 2022534586A5
- Authority
- JP
- Japan
- Prior art keywords
- ntecs
- cells
- therapeutic composition
- composition according
- endothelial cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962853452P | 2019-05-28 | 2019-05-28 | |
| US62/853,452 | 2019-05-28 | ||
| PCT/US2020/034932 WO2020243310A1 (en) | 2019-05-28 | 2020-05-28 | Compositions and methods for thymic regeneration and t-cell reconstitution |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022534586A JP2022534586A (ja) | 2022-08-02 |
| JP2022534586A5 true JP2022534586A5 (https=) | 2023-05-29 |
| JP7637418B2 JP7637418B2 (ja) | 2025-02-28 |
Family
ID=73553922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021570514A Active JP7637418B2 (ja) | 2019-05-28 | 2020-05-28 | 胸腺再生およびｔ細胞再構成のための組成物および方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220226391A1 (https=) |
| EP (1) | EP3976065A4 (https=) |
| JP (1) | JP7637418B2 (https=) |
| KR (1) | KR20220015451A (https=) |
| CN (1) | CN114340642A (https=) |
| AU (1) | AU2020283586A1 (https=) |
| CA (1) | CA3141989A1 (https=) |
| IL (1) | IL288439A (https=) |
| SG (1) | SG11202113119QA (https=) |
| WO (1) | WO2020243310A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2753441C2 (ru) | 2016-09-13 | 2021-08-16 | Ангиокрин Биосайенс, Инк. | Гематоэнцефалический барьер, содержащий сконструированные эндотелиальные клетки |
| WO2024155791A1 (en) * | 2023-01-18 | 2024-07-25 | Angiocrine Bioscience, Inc. | Use of umbilical vein endothelial cells for the treatment of lung injury |
| WO2025245461A1 (en) * | 2024-05-23 | 2025-11-27 | Thymofox Inc. | Methods of activating foxn1 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8465732B2 (en) * | 2007-01-19 | 2013-06-18 | Cornell Research Foundation, Inc. | Endothelial cells expressing adenovirus E4ORF1 and methods of use thereof |
| WO2016069911A1 (en) * | 2014-10-29 | 2016-05-06 | Jarrod Dudakov | Use of bmp4 for thymic regeneration |
| RU2743761C2 (ru) | 2014-12-19 | 2021-02-25 | Анджиокрин Биосайенс, Инк. | Биосовместимые имплантаты, содержащие сконструированные эндотелиальные клетки |
| RU2753441C2 (ru) * | 2016-09-13 | 2021-08-16 | Ангиокрин Биосайенс, Инк. | Гематоэнцефалический барьер, содержащий сконструированные эндотелиальные клетки |
-
2020
- 2020-05-28 KR KR1020217042865A patent/KR20220015451A/ko not_active Ceased
- 2020-05-28 CN CN202080053410.6A patent/CN114340642A/zh active Pending
- 2020-05-28 SG SG11202113119QA patent/SG11202113119QA/en unknown
- 2020-05-28 WO PCT/US2020/034932 patent/WO2020243310A1/en not_active Ceased
- 2020-05-28 CA CA3141989A patent/CA3141989A1/en active Pending
- 2020-05-28 US US17/614,521 patent/US20220226391A1/en active Pending
- 2020-05-28 AU AU2020283586A patent/AU2020283586A1/en not_active Abandoned
- 2020-05-28 JP JP2021570514A patent/JP7637418B2/ja active Active
- 2020-05-28 EP EP20813769.5A patent/EP3976065A4/en not_active Withdrawn
-
2021
- 2021-11-25 IL IL288439A patent/IL288439A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12559536B2 (en) | CD33 specific chimeric antigen receptors | |
| US20240041928A1 (en) | Genetically Modified Immune Cells Targeting NY-ESO-1 and Methods of Use Thereof | |
| EP1789435B1 (en) | A method for production of mature natural killer cell | |
| TW202140530A (zh) | 前列腺特異性膜抗原car及其使用方法 | |
| CN112204148A (zh) | 具有增强功能的修饰的免疫细胞及其筛选方法 | |
| CN115243713A (zh) | 用于递送修饰的淋巴细胞聚集体的方法和组合物 | |
| KR20220130712A (ko) | 치료 부위에서 면역계 반응을 자극하고 유지하기 위한 나노입자 시스템 | |
| JP2022534586A5 (https=) | ||
| JP2024534417A (ja) | インターロイキン－９受容体シグナル伝達ドメインを含むキメラ抗原受容体 | |
| JP2024509917A (ja) | 腫瘍溶解性ウイルスによる直交性ｉｌ－２の送達を用いた、固形腫瘍におけるｔ細胞の選択的刺激方法 | |
| CN101580817A (zh) | 含有细胞因子诱导杀伤细胞的细胞群的制造方法 | |
| JP2022541293A (ja) | がん細胞療法用のｐ２１発現単球 | |
| KR102338957B1 (ko) | 형질전환된 t세포를 이용한 제대혈 유래 자연살해세포의 배양방법 | |
| CN105585637B (zh) | 基于il-12稳定膜表达的肿瘤治疗剂及其制法和用途 | |
| US20180066253A1 (en) | Methods and compositions for modifying endothelial cells | |
| US20250177442A1 (en) | Boosting chimeric antigen receptor cells in the blood | |
| EP1697503B1 (en) | Cell culture with nm23, cell culture media comprising nm23 and therapeutic use of cells cultured in the presence of nm23 | |
| CN105622759A (zh) | IL-12/CD107a融合蛋白增强CTL抗肿瘤效果的治疗剂及其制法和用途 | |
| AU2022218162B9 (en) | Formulations and processes for car t cell drug products | |
| US20260027208A1 (en) | Host cells bearing kras binding protein and knockout of endogenous tcr and methods of use thereof | |
| US20240342280A1 (en) | Optimizing t cell differentiation state with micrornas | |
| JP2026509470A (ja) | 腫瘍治療のためのｃａｒ修飾因子の作製 | |
| WO2024153124A1 (zh) | 经修饰的原代t细胞及其用途 | |
| WO2025166113A1 (en) | Cell-free implants for in vivo recruitment, activation, and reprogramming of immune cells | |
| HK40112643A (zh) | 增强血液中的嵌合抗原受体细胞 |